Investors & Media

SEC Filing Details

Document Details

Form
Filing Date
Aug 9, 2021
Document Date
Aug 2, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Sangamo Therapeutics, Inc.
Issuer
SANGAMO BIOSCIENCES INC
Filer
WILLOUGHBY SCOTT B.